1Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: Report of the National Rosacea Society Expert Com- mittee on the Classification and Staging of Rosacea.J Am Acad Dermatol, 2002, 46(4): 584-587.
2Margolis DJ, Bowe WP, Hoffstad O, et al. Antibiotic treatment of acne may be associated with upper respiratory tract infections. Arch Dermatol, 2005, 141(9): 1132-1136.
3Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med, 2006, 355(7): 666-674.
4Ruhe JJ, Monson T, Bradsher RW, et al. Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature. Clin Infect Dis, 2005, 40( 10): 1429-1434.
5Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis, 2000, 66(4 Suppl): 7-13.
6Rebora A. The management of rosacea. Am J Clin Dermatol, 2002, 3(7): 489-496.
7Bikowski JB. Rosacea: a tiered approach to therapy. Cutis, 2000, 66(4 Suppl): 3-6.
8Bikowski JB. Subantimicrobial dose doxycycline for acne and rosacea. Skinrned, 2003, 2(4): 234-245.
9Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol, 2003, 139(4): 459-464.
10Thomas J, Walker C, Bmdshaw M. Long-term use of subantimicrobial dose doxycycline dose not lead to changes in antimicro- bial sisceptibility. J Periodontol, 2000, 71 ( 9 ): 1472-1483.
